Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Loss-of-function mutations in the Granulin (GRN) gene are causative of frontotemporal dementia with TAR DNA-binding protein-43 inclusions.
|
28304311 |
2017 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We investigated the contribution of rare variants in seven genes of known relevance to dementias (β-amyloid precursor protein (APP), PSEN1/2, MAPT (microtubule-associated protein tau), fused in sarcoma (FUS), granulin (GRN) and TAR DNA-binding protein 43 (TDP-43)) to PD and PD plus dementia (PD+D) in a discovery sample of 376 individuals with PD and followed by the genotyping of 25 out of the 27 identified variants with a minor allele frequency <5% in 975 individuals with PD, 93 cases with Lewy body disease on neuropathological examination, 613 individuals with Alzheimer's disease (AD), 182 cases with frontotemporal dementia and 1014 general population controls.
|
25604855 |
2015 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
|
21086759 |
2010 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Whereas wild-type UBQLN2 accumulates in intraneuronal deposits in several common age-related neurodegenerative diseases, mutations in the gene encoding this protein result in X-linked amyotrophic lateral sclerosis/frontotemporal dementia associated with TDP43 accumulation.
|
30333186 |
2018 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Fragments of the TAR DNA-binding protein 43 (TDP43) are major components of intracellular aggregates associated with amyotrophic lateral sclerosis and frontotemporal dementia.
|
29987190 |
2018 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These findings also document an association, in TDP43-proteinopathy patients, between heterogenous ribonucleoprotein pathology and RNA metabolism alterations and carry importance for neurodegenerative diseases, such as amyotrophic lateral sclerosis and frontotemporal dementia.
|
24462217 |
2014 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Clinical phenotypes and radiological findings in frontotemporal dementia related to TARDBP mutations.
|
25408367 |
2015 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
TARDBP mutation screening should be considered in familial frontotemporal dementia cases, even without signs or symptoms of motor neuron disease, especially when other more frequent causes of genetic frontotemporal dementia (i.e.
|
25853458 |
2015 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Novel TARDBP sequence variant and C9ORF72 repeat expansion in a family with frontotemporal dementia.
|
22892647 |
2015 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TDP-43 are associated with proteinaceous inclusions in neurons and are believed to be causative in neurodegenerative diseases such as frontotemporal dementia or amyotrophic lateral sclerosis.
|
28686708 |
2017 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea.
|
19609911 |
2009 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Endogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model.
|
23798570 |
2013 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease.
|
19655382 |
2009 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Frontotemporal lobar degeneration-associated pathologies segregated based on their cerebral atrophy profiles, according to the following scheme: asymmetric, relatively localized (predominantly temporal lobe) atrophy (TDP-43 type C); relatively symmetric, relatively localized (predominantly temporal lobe) atrophy (microtubule-associated protein tau mutations); strongly asymmetric, distributed atrophy (Pick's disease); relatively symmetric, predominantly extratemporal atrophy (corticobasal degeneration, fused-in-sarcoma pathology).
|
21908872 |
2011 |
Pick Disease of the Brain
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We interrogated pathological Alzheimer's disease (n = 247); other tauopathies (n = 95) including Pick's disease, corticobasal disease and progressive supranuclear palsy; the synucleinopathies (n = 164) including multiple system atrophy and Lewy body disease; the TDP-43 proteinopathies (n = 188) including frontotemporal lobar degeneration with TDP-43 inclusions and amyotrophic lateral sclerosis; and a minimal pathology group (n = 72).
|
29878075 |
2018 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia.
|
29545601 |
2018 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The present study represents the first attempt to investigate the endocannabinoid system in an alternative model, the transgenic mouse model of TAR-DNA binding protein-43 (TDP-43), a protein related to ALS and also to frontotemporal dementia.
|
25819934 |
2015 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
|
31690696 |
2020 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
TAR DNA-binding protein 43 (TDP-43) is a major protein component of pathological inclusions in amyotrophic lateral sclerosis and frontotemporal dementia.
|
30372676 |
2018 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
The TAR DNA-binding protein (TDP-43) self-assembles into prion-like aggregates considered to be the structural hallmark of amyotrophic lateral sclerosis and frontotemporal dementia.
|
31782904 |
2019 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
Recent evidence shows that TDP-43, a RNA-binding protein associated with frontotemporal dementia and amyotrophic lateral sclerosis, exists in a physiological and functional nuclear oligomeric form, whose destabilization may represent a prerequisite for misfolding, toxicity and subsequent pathological deposition.
|
29070802 |
2017 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
There are no effective TDP-43-directed therapies for ALS or related TDP-43 proteinopathies, such as frontotemporal dementia.
|
28405022 |
2017 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
TDP-43 inclusions also characterize patients with GGGGCC (G4C2) hexanucleotide repeat expansion in C9orf72 that causes the most common genetic form of amyotrophic lateral sclerosis and frontotemporal dementia (C9ALS/FTD).
|
30239641 |
2018 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
TDP-43 was recently identified as the major pathological protein in sporadic amyotrophic lateral sclerosis and in the most common pathological subtype of frontotemporal dementia, frontotemporal lobar degeneration with ubiquitinated inclusions.
|
18989115 |
2008 |
Pick Disease of the Brain
|
0.100 |
Biomarker
|
disease |
BEFREE |
TDP-43 and frontotemporal dementia.
|
19664364 |
2009 |